Do Not Hold Metoprolol
In an 82-year-old patient with a heart rate of 50 bpm on metoprolol 25 mg daily, the medication should NOT be routinely held based solely on this heart rate, as a resting heart rate of 50 bpm is not an absolute contraindication to beta-blocker therapy.
Clinical Assessment Required
The decision to continue or hold metoprolol depends on the presence or absence of symptoms and hemodynamic stability, not the heart rate number alone:
Continue Metoprolol If:
- Patient is asymptomatic (no dizziness, syncope, presyncope, fatigue, or dyspnea)
- Blood pressure is adequate (systolic BP ≥90 mm Hg)
- No evidence of heart failure decompensation
- No high-grade AV block (second- or third-degree heart block) on ECG
- Patient is hemodynamically stable
Consider Holding or Reducing Dose If:
- Symptomatic bradycardia (dizziness, lightheadedness, syncope, confusion)
- Hypotension (systolic BP <90 mm Hg or >30 mm Hg below baseline) 1
- Signs of heart failure or low output state
- Second- or third-degree heart block or sick sinus syndrome without pacemaker 1, 2
- Heart rate <50 bpm with symptoms 1
Evidence-Based Rationale
Guidelines consistently identify symptomatic bradycardia rather than a specific heart rate threshold as the contraindication. The 2013 ACCF/AHA STEMI guidelines specify that beta-blockers should be avoided in patients with "increased risk for cardiogenic shock" but define risk factors as heart rate <60 bpm **combined with other factors** (age >70 years, systolic BP <120 mm Hg, prolonged symptom duration) 1. A heart rate of 50 bpm alone, particularly in an asymptomatic elderly patient, does not mandate discontinuation.
The 2008 ESC Heart Failure guidelines note that sinus bradycardia <50 bpm is listed as a contraindication to beta-blocker initiation in heart failure patients, but this applies to starting therapy, not continuing established therapy 3. For patients already on beta-blockers, the guidance is to "reduce dose if necessary, but discontinue only if clearly necessary" 4.
Practical Management Algorithm
- Assess symptoms: Ask specifically about dizziness, fatigue, syncope, dyspnea
- Check blood pressure: Ensure systolic BP ≥90 mm Hg
- Obtain ECG: Rule out high-grade AV block
- Evaluate indication: Confirm why patient is on metoprolol (post-MI, heart failure, hypertension, atrial fibrillation)
If asymptomatic with adequate BP and no AV block: Continue metoprolol 25 mg daily unchanged
If symptomatic or hypotensive:
- Hold current dose
- Increase diuretics or reduce other vasodilators first 4
- Consider dose reduction to 12.5 mg daily rather than complete discontinuation
- Reintroduce/uptitrate when patient stabilizes 4
Common Pitfalls
Do not reflexively hold beta-blockers for asymptomatic bradycardia in the 50s. This is a common error that deprives patients of proven mortality benefit, particularly post-MI or in heart failure 1, 2. The target resting heart rate for beta-blocker therapy is actually 50-60 bpm unless limiting side effects occur 2.
Elderly patients may have lower baseline heart rates and tolerate rates in the 50s well 5. The FDA label notes that metoprolol should be "initiated at low doses with cautious gradual dose titration" in elderly patients but does not specify a heart rate cutoff for discontinuation 5.
If the patient has a clear indication (post-MI, heart failure with reduced ejection fraction, atrial fibrillation rate control), the benefits of continued beta-blockade typically outweigh concerns about asymptomatic bradycardia in the 50s 1, 2, 3.